Weight-loss drug cuts heart attack risk regardless of kilograms shed, study finds

A recent study has revealed that the weight-loss drug semaglutide significantly reduces the risk of heart attacks and strokes, regardless of the amount of weight lost. This groundbreaking research highlights the potential broader benefits of such medications, while also noting that a decrease in waist size, indicative of reduced belly fat, is associated with improved heart health. This finding is crucial as it suggests that even modest weight loss can have substantial cardiovascular benefits, making semaglutide a promising option for those at risk.